Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor
- 31 March 2008
- journal article
- Published by Elsevier BV in NeuroToxicology
- Vol. 29 (2), 294-300
- https://doi.org/10.1016/j.neuro.2007.12.001
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Reduced Purkinje Cell Number in Essential TremorArchives of Neurology, 2008
- Pesticide exposure might be a strong risk factor for Parkinson's diseaseAnnals of Neurology, 2007
- Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremorMovement Disorders, 2006
- Harmaline‐induced tremor as a potential preclinical screening method for essential tremor medicationsMovement Disorders, 2005
- Cerebellar metabolic symmetry in essential tremor studied with 1H magnetic resonance spectroscopic imaging: Implications for disease pathologyMovement Disorders, 2004
- Increased β-Carboline 9N-Methyltransferase Activity in the Frontal Cortex in Parkinson's DiseaseNeurobiology of Disease, 2000
- How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the worldMovement Disorders, 1998
- Harmaline competitively inhibits [3H]MK-801 binding to the NMDA receptor in rabbit brainBrain Research, 1997
- Human exposure to mutagenic/carcinogenic heterocyclic amines and comutagenic β-carbolinesMutation research. Reviews in mutation research, 1997
- Ethanol effects on harmaline-induced tremor and increase of cerebellar cyclic GMPLife Sciences, 1984